Immutep

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep and other ETFs, options, and stocks.

About IMMP

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alpha (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). 

CEO
Marc Voigt
CEOMarc Voigt
Employees
—
Employees—
Headquarters
Sydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded
1987
Founded1987
Employees
—
Employees—

IMMP Key Statistics

Market cap
300.27M
Market cap300.27M
Price-Earnings ratio
-7.51
Price-Earnings ratio-7.51
Dividend yield
—
Dividend yield—
Average volume
222.79K
Average volume222.79K
High today
$2.08
High today$2.08
Low today
$2.01
Low today$2.01
Open price
$2.03
Open price$2.03
Volume
61.40K
Volume61.40K
52 Week high
$2.71
52 Week high$2.71
52 Week low
$1.32
52 Week low$1.32

IMMP News

TipRanks 3d
Immutep Limited Announces 2025 AGM with Key Resolutions

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

TipRanks 5d
Immutep Showcases Promising Lung Cancer Treatment Results at ESMO Congress 2025

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.